panel 1: patient safety moderated by scott williams

21
How Have American Patients Been Impacted by Unsafe Medicines? Patient Risk, 2010 - 2013 #fakedrugs #PSM2013

Upload: the-partnership-for-safe-medicines

Post on 21-Jun-2015

331 views

Category:

Health & Medicine


2 download

TRANSCRIPT

Page 1: Panel 1: Patient Safety Moderated by Scott Williams

How Have American Patients Been Impacted by Unsafe Medicines?

Patient Risk, 2010 - 2013

#fakedrugs #PSM2013

Page 2: Panel 1: Patient Safety Moderated by Scott Williams

The Problem of Misbranded Treatments ● The United States has seen a rash of cases in

which medical professionals have purchased non-FDA approved medicines and other medical devices.

● Illegal distributors make a profit selling drugs from sources that aren’t trustworthy -- illegally imported, expired, stolen, damaged by bad handling.

● Doctors and pharmacist generate profit by billing insurance, Medicare and patients the full price for legitimate treatments. #fakedrugs

#PSM2013#fakedrugs #PSM2013

Page 3: Panel 1: Patient Safety Moderated by Scott Williams

The Problem of Misbranded Treatments ●This problem threatens a broad range of

patients who must rely on their healthcare providers for safe treatments.

●Infused, injected and inhaled drugs are particularly easy to counterfeit; the main challenge is packaging.

Page 4: Panel 1: Patient Safety Moderated by Scott Williams

Patients, too, break the supply chain by buying from fake online pharmacies (often claiming to be Canadian) or other unapproved avenues.

Recent examples:● Weight loss pills ● Flu Treatments● Adderall

Patients Buy Counterfeits in Pursuit of Savings or

Magical Solutions

#fakedrugs #PSM2013#fakedrugs #PSM2013

Page 5: Panel 1: Patient Safety Moderated by Scott Williams

Patients Buy Counterfeits in Pursuit of Savings or Magical SolutionsThese consumers don't realize that:

● Drugs they buy from Canadian online pharmacies are not from Canada's legitimate drug supply.

● Despite the assurances of drug exporters about "Tier One" countries the FDA has never designated any country from which it is universally safe to import medicine.

● If it’s not FDA-approved, you can’t be assured that the contents are safe, or what they’re supposed to be.

#fakedrugs #PSM2013

Page 6: Panel 1: Patient Safety Moderated by Scott Williams

Misbranded Treatments “Mirena” IUDs

What is the impact?● In 2010, 2,140,000 women in the US used IUDs.

● Non-FDA approved IUDs may cause unintended pregnancy or infections.

#fakedrugs #PSM2013#fakedrugs #PSM2013

Page 7: Panel 1: Patient Safety Moderated by Scott Williams

Misbranded Treatments Botox

Botox (onabotulinumtoxinA) -- injected anti-wrinkle treatment, also for repetitive neck spasms and chronic migraines● Multiple cases. One false distributor sold

almost 6,000 doses of unapproved, imported Botox and Juviderm.

● FDA warnings to over 350 medical offices, including a Dallas area hospital, since 2012.

#fakedrugs #PSM2013#fakedrugs #PSM2013

Page 8: Panel 1: Patient Safety Moderated by Scott Williams

Misbranded Treatments BotoxWhat’s the Impact?• 2.95 million Americans use Botox for a variety of reasons,

both cosmetic and medical.

• Since 2005, fake Botox has been found in investigations in Los Angeles, Miami, and Kentucky.

• Patients have been disfigured and suffered respiratory paralysis from counterfeit Botox.

Page 9: Panel 1: Patient Safety Moderated by Scott Williams

Counterfeit Medicines and Chronic Illness● Patients are easily exploited while they are seeking better

or less expensive treatments.

● Patients taking ongoing medications are at high risk because they have longer exposure to more medicines.

● Poor response to counterfeit or substandard medicines may be misdiagnosed as treatment failure.

#fakedrugs #PSM2013

Page 10: Panel 1: Patient Safety Moderated by Scott Williams

Misbranded Treatments Osteoporosis DrugsAclasta (zoledronate) and Prolia (denosumab) -- injected medicines to treat osteoporosis.● Since September 2012, the FDA has warned

23 US medical practices that they may have purchased unapproved versions of these treatments.

What’s the Impact?● 40 million Americans suffer from osteoporosis

or are at high risk.

#fakedrugs #PSM2013

Page 11: Panel 1: Patient Safety Moderated by Scott Williams

Diverted TreatmentsHIV Drugs

MOMS Pharmacy, New York, 2012

● 4 individuals allegedly resold black market HIV and AIDS medications that included drugs previously dispensed to individuals, as well as stolen and expired medications.

● MOMS Pharmacy and its parent company, Allion Healthcare sought reimbursement from Medicaid.

● The alleged scheme was a multi-state operation that netted millions of dollars. #fakedrugs

#PSM2013

Page 12: Panel 1: Patient Safety Moderated by Scott Williams

Diverted TreatmentsHIV Drugs

What’s the Impact?● 1.1 million people are living with

AIDS in the United States.

‣ (130,000 in New York State)

● Expired or poorly handled treatments are less effective (or ineffective). HIV/AIDS patients rely on these medicines to control their illness. Ineffective treatments lead to decline and death.

#fakedrugs #PSM2013

Page 13: Panel 1: Patient Safety Moderated by Scott Williams

Misbranded Drugs - DialysisAmerican Inhalation Medication Specialists, Inc., Tennessee, May 2013

● Tennessee pharmacist Robert Harshbarger, Jr. substituted a cheap Chinese import for the iron sucrose used to treat anemia kidney dialysis patients.

● Benefit programs paid more than $848,000 for the misbranded iron sucrose between 2004 and 2008.

● Several patients of Kansas Dialysis Services, L.C were treated with the misbranded dialysis drugs.

#fakedrugs #PSM2013

Page 14: Panel 1: Patient Safety Moderated by Scott Williams

Misbranded Drugs - DialysisWhat’s the Impact?

● At the end of 2009, more than 871,000 Americans were being treated for End Stage Renal Disease.

● Untreated (or ineffectively treated) iron deficiency anemia causes fatigue, shortness of breath, chest pain. Severe cases can cause heart problems, infections and other complications.

● Adulterated iron sucrose could cause severe illness and death.

#fakedrugs #PSM2013

Page 15: Panel 1: Patient Safety Moderated by Scott Williams

Fake Drugs - Diabetes● 2013: FDA warned diabetics to beware of illegal

“natural” remedies for the treatment of diabetes.

● Other cases around the world:○ 2011 - Fake test strips in India○ 2009 - Counterfeit insulin needles in the UK○ 2006 - Counterfeit test strips in the US

#fakedrugs #PSM2013

Page 16: Panel 1: Patient Safety Moderated by Scott Williams

Fake Drugs - DiabetesWhat’s the Impact?

● As of 2011, 18.8 million Americans had been diagnosed with diabetes.

● Diabetes contributes to 231,404 deaths each year.● Ineffective treatment and poor blood sugar control

cause heart disease, stroke, blindness, kidney disease, amputations, and poor immunity to other diseases.

#fakedrugs #PSM2013

Page 17: Panel 1: Patient Safety Moderated by Scott Williams

Misbranded TreatmentsAvastin

● McCleod Blood and Cancer Center○ Kincaid, and his business

manager purchased misbranded drugs, and administered them to patients.

○ Kincaid made at least $500,000 by seeking reimbursement through the Medicare and Medicaid/ TennCare programs as well as other health benefits programs.

#fakedrugs #PSM2013

Page 18: Panel 1: Patient Safety Moderated by Scott Williams

Misbranded TreatmentsAvastin

Kincaid and the

manager conspired

to hide the illegal

purchases from

nursing staff who

recognized that the

treatments were

counterfeit.

#fakedrugs #PSM2013

Page 19: Panel 1: Patient Safety Moderated by Scott Williams

Misbranded TreatmentsAvastinWhat’s the Impact?

It’s difficult to know because the drugs were administered to gravely ill patients who might have died anyway.

"People who receive a fake medication instead of Avastin could have lost several months of their lives.” – Dr. Nimesh Nagarsheth, oncologist

#fakedrugs #PSM2013

Page 20: Panel 1: Patient Safety Moderated by Scott Williams

What’s the scope of this problem?

We don’t know.

Misbranded Treatments - Avastin

#fakedrugs #PSM2013

Page 21: Panel 1: Patient Safety Moderated by Scott Williams

PanelistsScott Williams, Director, American Cancer Society Cancer Action Network

Suzanne Willard, President-Elect, Association of Nurses in Aids Care (PSM member)

William E. Arnold, CEO and Vice-Chair, Community Access National Network (PSM member)

Christopher Weaver, Health & Science Reporter, The Wall Street Journal

#fakedrugs #PSM2013